Resurgence of COVID-19 and diabetes in India.

Pal, Rimesh; Bhadada, Sanjay K; Misra, Anoop

Pal, Rimesh; Bhadada, Sanjay K; Misra, Anoop.

Pal R; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Bhadada SK; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India. Electronic address: bhadadask@rediffmail.com.
Misra A; Centre of Nutrition & Metabolic Research (C-NET), National Diabetes, Obesity and Cholesterol Foundation (N-DOC), SDA, New Delhi, India; Diabetes Foundation (India), SDA, New Delhi, India; Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chirag Enclave, Nehru Place, New Delhi, India. Electronic address: anoopmisra@gmail.com.

Diabetes Metab Syndr ; 15(3): 1037-1038, 2021.

Article in English | MEDLINE | ID: covidwho-1231990

Subject(s)

COVID-19/complications; Diabetes Complications/virology; COVID-19/epidemiology; Comorbidity; Diabetes Complications/epidemiology; Humans; India/epidemiology; SARS-CoV-2

Keywords

COVID-19; Diabetes; Resurgence; Second wave

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Complications / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Diabetes Metab Syndr Year: 2021 Document Type: Article Affiliation country: J.dsx.2021.04.024

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google